Development

INSIGHTS ON DRUG DEVELOPMENT

Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
Solving Bioavailability Challenges In bRo5 Drugs
Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.
Using SEC For Reliable Biotherapeutic Peptide Analysis
Discover a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable, high-resolution analysis.
Alzheimer's Disease Pathway
Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.

Method Development For Forced Degradation Of GLP-1 Agonist
3/18/2026

Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
Effect Of Column Chemistry On The Separation Of GLP-1 Peptides
7/29/2026

Small changes in mobile phase, temperature, and column chemistry can affect the detection of GLP-1 peptide impurities. Learn which conditions improve resolution for challenging peptide analyses.
Molecular Properties Of PROTACs And The Relationship To Formulation Design
3/4/2025

Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
Navigating The Regulatory Space To Biosimilar Approval
9/1/2025

The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
Excipients For Respiratory Delivery Of Biologics
9/9/2026

With only 105 FDA-approved excipients for nasal and inhalation routes, formulating biologics for respiratory delivery demands precise excipient selection across both liquid and solid dosage forms.

High Potency API Development And Manufacturing

Our HPAPI development and manufacturing spans preclinical through commercial supply across 13 global sites, with SafeBridge-certified containment and 30 years of cytotoxic compound expertise.
Predict NMR Spectra With Confidence
The Most Accurate 1D and 2D NMR Predictors

From experimental design to data interpretation, ACD/Labs’ NMR predictors can significantly speed up your workflow. Use ACD/NMR Predictors to:
- Predict a complete set of 1D and 2D NMR spectra, for ¹H, ¹³C, ¹⁵N, ¹⁹F, and ³¹P nuclei from a chemical structure
- Calculate chemical shifts and coupling constants in seconds
- Train the algorithms with in-house data to improve accuracy for novel chemical space
AUC Sample Characterization Instrument
- Enables sample recovery
- Avoids dilution effects
- Analyzes samples in a matrix-free environment
- Has minimal buffer constraints
Pre-Formulation And Material Sciences

Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
ADC And Bioconjugation Center Of Excellence

Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.